KVK Tech Announces FDA-Approval of Lomaira(TM) (phentermine hydrochloride USP) 8 mg tablets, CIV, A Low-Cost, Low-Dose Phentermine That Can Be Used Up To Three Times Daily for Weight Reduction

NEWTOWN, Pa., Sept. 20, 2016 -- (Healthcare Sales & Marketing Network) -- KVK Tech, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved Lomaira (phentermine hydrochloride USP) 8 mg tablets CIV, a low-cost, low-dose prescrip... Biopharmaceuticals, FDA KVK Tech, Lomaira, phentermine, anorectic, obesity

http://salesandmarketingnetwork.com/news_release_bs.html?ID=2041624

Source: HSMN NewsFeed - September 20, 2016 Category: Pharmaceuticals Source Type: news